CD44 and breast carcinoma: Further studies demonstrated that an Os (II) complex with a dca ligand also eradicated CSCs in MCF-7 and SKBR-3 human breast cancer cells, targeting CD44-positive, CD24-negative CSC-like cells and inhibiting mammosphere formation.